|
Volumn 5, Issue 9, 1996, Pages 1079-1099
|
Immunological adjuvants: Mechanisms of action and clinical applications
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALUMINUM HYDROXIDE;
ALUMINUM PHOSPHATE;
ALUMINUM SALT;
CORD FACTOR;
CYTOKINE;
DRUG CARRIER;
FREUND ADJUVANT;
IMMUNOLOGICAL ADJUVANT;
IMMUNOMODULATING AGENT;
LIPOSOME;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
MURAMYL DIPEPTIDE;
MURAMYL DIPEPTIDE DERIVATIVE;
MUROCTASIN;
MYCOLIC ACID;
N ACETYLMURAMYLTHREONYL DEXTRO ISOGLUTAMINE;
PHOSPHORYL LIPID A;
POLYOXYETHYLENE;
POLYSORBATE 80;
QS 21;
SAPONIN;
SQUALANE;
TITERMAX;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VACCINE;
ANTIGEN PRESENTATION;
CLINICAL TRIAL;
DRUG FORMULATION;
DRUG MECHANISM;
EMULSION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOMODULATION;
IMMUNOPOTENTIATION;
NONHUMAN;
PHARMACEUTICS;
REVIEW;
VACCINATION;
|
EID: 0029785488
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.9.1079 Document Type: Review |
Times cited : (9)
|
References (0)
|